CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Long Term Provisions | ₹66 Cr | ₹39 Cr | ₹32 Cr | ₹25 Cr |
What is the latest Long Term Provisions ratio of CORONA REMEDIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹66 Cr |
| Mar2025 | ₹39 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹25 Cr |
How is Long Term Provisions of CORONA REMEDIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹66 Cr | 71.12 | |
| Mar2025 | ₹39 Cr | 20.55 | |
| Mar2024 | ₹32 Cr | 29.12 | |
| Mar2023 | ₹25 Cr | - | |
Compare Long Term Provisions of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,570.5 Cr | -5.9% | -1.6% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -5.9% |
-1.6% |
|
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses